Sumagang, Jerick .
HRN: 22-44-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/05/2023
03/11/2023
IV DRIP
450mg
Q8
T/C Sepsis, VAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes